MET Inhibition in Advanced NSCLC: Molecular Testing for METex14 and Emerging Options

Get up to date on testing for METex14 and incorporating selective MET inhibitors into the care of your patients with METex14-altered NSCLC with an on-demand Webcast and downloadable slides from a live Webinar video roundtables podcasts and expert-authored commentaries.

Share

Program Content

Activities

<i>MET</i>ex14+ NSCLC: FAQ Part 1
MET Exon 14 Mutation–Positive NSCLC: FAQ Part 1
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: August 28, 2020

Expires: August 27, 2021

<i>MET</i>ex14+ NSCLC: FAQ Part 2
MET Exon 14 Mutation–Positive NSCLC: FAQ Part 2
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: August 28, 2020

Expires: August 27, 2021

Activities

<i>MET</i>ex14+ NSCLC
An Overview of MET Exon 14 Mutation Testing and Treatment in Advanced NSCLC
Congratulations: You achieved a completion on 04/09/2022
<i>MET</i>ex14 Testing in NSCLC
Focus on Molecular Testing for MET Exon 14–Skipping Mutations in Advanced NSCLC
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: August 20, 2020

Expires: August 19, 2021

Slides: <i>MET</i>ex14 Testing in NSCLC
Focus on Molecular Testing for MET Exon 14–Skipping Mutations in Advanced NSCLC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 20, 2020

Expires: August 19, 2021

<i>MET</i>ex14 Therapy in NSCLC
Focus on Therapy for MET Exon 14 Mutations in Advanced NSCLC
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: August 31, 2020

Expires: August 30, 2021

Slides: <i>MET</i>ex14 Therapy in NSCLC
Focus on Therapy for MET Exon 14 Mutations in Advanced NSCLC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 31, 2020

Expires: August 30, 2021

Activities

Slides: Targeting <i>MET</i>ex14 NSCLC
Emerging Therapies and Testing for METex14 in Advanced NSCLC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 20, 2020

Expires: August 19, 2021

Targeting <i>MET</i>ex14 NSCLC
Emerging Therapies and Testing for METex14 in Advanced NSCLC
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: August 20, 2020

Expires: August 19, 2021

Activities

Patient Case: <i>MET</i>ex14+ NSCLC
How I Am Using Selective MET Inhibitors in Patients With MET Exon 14–Positive NSCLC
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 14, 2020

Expires: August 13, 2021

Activities

<i>MET</i> Mutations in NSCLC
MET Mutations: Mastering the Features of and Testing for a New Target in NSCLC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: May 29, 2020

Expires: May 28, 2021

MET TKIs in <i>MET</i>ex14+ NSCLC: Tepotinib
MET-Targeted Therapies in Development: Tepotinib, Crizotinib, Savolitinib, and Combinations
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: May 29, 2020

Expires: May 28, 2021

MET TKIs in <i>MET</i>ex14+ NSCLC: Capmatinib
MET-Targeted Therapies in Development: Capmatinib, Acquired Resistance to MET TKIs, and Next-Line Choices
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: May 29, 2020

Expires: May 28, 2021

Provided by

ProCE Banner

Supporters

This educational activity is supported by an independent grant from the Healthcare business of

Merck KGaA